TGen Drug Development (TD2) offers cost reduction programs through advanced technology and economies of scale, along with comprehensive billing to accommodate your budget parameters. The complete service offering includes:

Preclinical Services
TD2 supports its clinical efforts by also offering preclinical services and innovations. For example we have the ability to design clinically relevant animal models that are more precise analogs of the human condition. TD2 also has the capability to design in vitro and in vivo testing strategies that to evaluate a client's compound in unique ways that predict optimal development pathways for a drug (for example determining how to best use an agent in combination with other experimental or FDA-approved treatments). [more information]

Clinical Services
TD2's team of dedicated scientific and medical professionals provide a comprehensive range of clinical services to help clients around the world move a compound from the lab bench to a pivotal trial. TD2 delivers customizable design, oversight and analysis solutions for all phases of clinical development utilizing our De-Risk approach. The heart of De-Risk is the synergy of genomic, informatics, preclinical and clinical innovations, plus the integration of our world class project managers into your team to further accelerate and augment the development of your program. [more information]

Regulatory Affairs Services
TD2 provides a broad range of regulatory expertise and services with integrated project management to ensure that your program runs seamlessly into clinical development. Our reputation of excellence in strategy, writing and submissions stems from our industry experienced team who are committed to the success of our clients. Whether your organization needs a full turn-key project or a customized selection of services TD2 stands ready to meet all of your regulatory affairs needs. [more information]